The Sinclair Method: Can Naltrexone Before Drinking Actually Work?
The Sinclair Method (TSM) challenges a foundational assumption of traditional addiction treatment: that abstinence is the only goal. Instead, TSM uses the opioid antagonist naltrexone, taken specifically before drinking, to gradually extinguish the brain's reward response to alcohol. It sounds too good to be true — but published evidence supports its efficacy for many patients.
The Sinclair Method works through pharmacological extinction: naltrexone blocks opioid receptors, preventing the endorphin release that makes alcohol pleasurable. Over 3–9 months of consistently taking naltrexone before every drinking session, the brain's learned association between alcohol and reward weakens, leading to reduced consumption in 78% of patients in published studies.
How TSM Works (Step by Step)
- Prescription: A physician prescribes naltrexone 50mg tablets (or sometimes nalmefene in Europe)
- Targeted dosing: Take one tablet 1–2 hours before any drinking occasion (not daily unless drinking daily)
- Continue drinking: You are not asked to stop. The naltrexone blocks the pleasurable endorphin response while you drink
- Pharmacological extinction: Over weeks and months, the brain gradually unlearns the association between alcohol and reward
- Gradual reduction: Most patients naturally drink less over 3–9 months without willpower or abstinence commitment
- Endpoint: Many reach abstinence or clinically insignificant drinking levels (WHO low-risk guidelines)
| Factor | Traditional Abstinence Model | Sinclair Method (TSM) |
|---|---|---|
| Goal | Complete abstinence from day one | Gradual reduction; abstinence may or may not be the endpoint |
| Approach | Behavioral and spiritual (AA, therapy) | Pharmacological (naltrexone before drinking) |
| Requires willpower | Significant | Minimal — the medication does the work |
| Published compliance rates | Variable (50–70% for residential, 20–40% outpatient) | High (78% in Finnish studies) |
| Timeline to effect | Immediate (if abstinent) | 3–9 months of gradual reduction |
| Success metric | Days sober / total abstinence | Reduced heavy drinking days, total consumption |
| Cost | $10,000–$60,000 (residential) | $30–$100/month (naltrexone) |
The Evidence
TSM is based on research by Dr. John David Sinclair at the National Institute for Health and Welfare in Finland. Key findings:
- Original Finnish studies: 78% of patients using targeted naltrexone reduced drinking to WHO low-risk levels or abstinence within 3–9 months
- COMBINE trial (2006, JAMA): The largest US alcohol treatment trial (1,383 patients) found naltrexone superior to placebo for reducing heavy drinking days. Though not designed specifically for TSM (daily dosing was used), it confirmed naltrexone's anti-drinking effect
- Cochrane Review (2010): Meta-analysis of 50 trials confirmed naltrexone reduces heavy drinking days by 17% compared to placebo and reduces the rate of return to any drinking by 5%
The evidence is real. TSM is not a fringe treatment — naltrexone for alcohol use disorder is FDA-approved, and targeted dosing before drinking is a recognized clinical approach, even if not the dominant one in US addiction medicine.
Based on Sinclair's published Finnish cohort data and subsequent replication studies. Individual results vary.
TSM is designed for alcohol use disorder specifically. It does not address polysubstance use, is not appropriate for opioid-dependent patients (naltrexone blocks opioid effects and can precipitate withdrawal), and may not be sufficient for severe alcohol dependence with medical complications (liver disease, withdrawal seizure history) where medical detox and residential treatment should come first.
Access in Colombia
Naltrexone is available by prescription in Colombia at a fraction of US pricing. Patients traveling for other treatment can initiate TSM with a Colombian physician, establish the protocol, and continue with their US prescriber upon return. Colombian pharmacies typically dispense naltrexone 50mg for $20–$40 per month, compared to $50–$200 in the US.
SAMHSA National Helpline: 1-800-662-4357 (free, confidential, 24/7, English and Spanish).
988 Suicide & Crisis Lifeline: 988 (call or text, 24/7).
Frequently Asked Questions
Initially, yes — that is the mechanism. Naltrexone blocks the reward signal during drinking, gradually weakening the association. Over time, you naturally drink less. Many patients eventually reach abstinence, but the pathway goes through continued (decreasing) drinking, not cold-turkey cessation.
Any licensed physician can prescribe naltrexone for alcohol use disorder. However, many US physicians are not familiar with the TSM protocol specifically (targeted dosing before drinking rather than daily use). Seek a physician experienced with TSM or telehealth services that specialize in it.
Yes. TSM addresses the pharmacological reinforcement pathway; therapy and support groups address psychological, social, and behavioral aspects of alcohol use. They are complementary. However, some AA groups may view continued drinking (even with decreasing consumption) as inconsistent with the program.
TSM is typically needed for 3–9 months of consistent use, with ongoing as-needed use after that. Some patients reach a point where they no longer desire alcohol and discontinue the medication. Others use it indefinitely as a safety net for social situations.
Disulfiram works through punishment (making you sick if you drink), while naltrexone works through extinction (making drinking unrewarding). Published evidence for naltrexone is stronger than for disulfiram. Disulfiram also has compliance challenges — patients often stop taking it to drink.